Clinical Trial Update: Molecular Hydrogen for Cognitive Function and Performance in Elderly [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating molecular hydrogen for cognitive function and performance in elderly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Molecular Hydrogen (molecular hydrogen (H2))

Snippet

Sponsor: University of Novi Sad, Faculty of Sport and Physical Education | Conditions: Cognitive Impairments, Aging | Phase 3 | Status: COMPLETED